Abstract |
Leukemogenesis is characterized by chromosomal rearrangements with additional molecular disruptions, yet the cooperative mechanisms are still unclear. Using whole-exome sequencing of a pair of monozygotic twins who were discordant for childhood acute lymphoblastic leukemia (ALL) with ETV6-RUNX1 (E/R) gene fusion successively after birth, we identified the R209C mutation of G protein subunit α o1 (GNAO1) as a new ALL risk loci. Moreover, GNAO1 missense mutations are recurrent in ALL patients and are associated with E/R fusion. Ectopic expression of the GNAO1 R209C mutant increased its GTPase activity and promoted cell proliferation and cell neoplastic transformation. Combined with the E/R fusion, the GNAO1 R209C mutation promoted leukemogenesis through activating PI3K/Akt/mTOR signaling. Reciprocally, activated mTORC1 phosphorylated p300 acetyltransferase, which acetylated E/R and thereby enhanced the E/R transcriptional activity of GNAO1 R209C. Thus, our study provides clinical evidence of the functional cooperation of GNAO1 mutations and E/R fusion, suggesting GNAO1 as a therapeutic target in human leukemia.
|
Authors | Lili Song, Bo Yu, Yi Yang, Jianwei Liang, Yingwen Zhang, Lixia Ding, Tianyi Wang, Xinyu Wan, Xiaomin Yang, Jingyan Tang, Shengyue Wang, Benshang Li, Yanxin Li, Haizhong Feng |
Journal | Blood
(Blood)
Vol. 137
Issue 9
Pg. 1181-1191
(03 04 2021)
ISSN: 1528-0020 [Electronic] United States |
PMID | 32898863
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 by The American Society of Hematology. |
Chemical References |
- Core Binding Factor Alpha 2 Subunit
- GNAO1 protein, human
- Oncogene Proteins, Fusion
- TEL-AML1 fusion protein
- GTP-Binding Protein alpha Subunits, Gi-Go
|
Topics |
- Animals
- Carcinogenesis
(genetics)
- Cell Line, Tumor
- Core Binding Factor Alpha 2 Subunit
(genetics)
- Female
- GTP-Binding Protein alpha Subunits, Gi-Go
(genetics)
- HEK293 Cells
- Humans
- Male
- Mice
- Models, Molecular
- Mutation
- Mutation, Missense
- Oncogene Proteins, Fusion
(genetics)
- Point Mutation
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(genetics)
|